Literature DB >> 19950815

Oral branched-chain amino acids administration improves impaired liver dysfunction after radiofrequency ablation therapy for hepatocellular carcinoma.

Toru Ishikawa1, Imai Michitaka, Hiroteru Kamimura, Kazuo Higuchi, Tomoyuki Kubota, Kei-ichi Seki, Hironobu Ohta, Toshiaki Yoshida, Tomoteru Kamimura.   

Abstract

BACKGROUND/AIMS: Radiofrequency ablation (RFA) is a new modality for hepatocellular carcinoma (HCC). However, the effects of RFA on hepatic reserve have not yet been thoroughly studied. In the present study, it was evaluated the effect of branched chain amino acid (BCAA) administration after RFA.
METHODOLOGY: Fifty-seven patients with initial, single HCC lesions measuring not more than 30mm in whom RFA was selected in first-line therapy were enrolled. Twenty-eight patients with the Child-Pugh B/C grade who received RFA therapy were divided into two groups: 11 who received a BCAA-enriched nutrient mixture, and 17 who did not. Changes in serum albumin were evaluated before RFA and 1, 6 and 12 months after RFA.
RESULTS: Multivariate analysis showed that the Child-Pugh grading is the most important factor related to intrahepatic distant recurrence following by RFA. Serum albumin levels decreased 1 month after RFA. Although a tendency toward recovery was noted 6 months after RFA, a decreasing tendency was noted again one year after RFA compared to the pre-RFA baseline. However, a tendency toward improvement was noted in Child-Pugh B grade patients who received BCAA mixture.
CONCLUSIONS: BCAA mixture made it possible to maintain serum albumin levels and hepatic reserve.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19950815

Source DB:  PubMed          Journal:  Hepatogastroenterology        ISSN: 0172-6390


  6 in total

Review 1.  Perioperative nutritional support and fluid therapy in patients with liver diseases.

Authors:  Yongliang Sun; Zhiying Yang; Haidong Tan
Journal:  Hepatobiliary Surg Nutr       Date:  2014-06       Impact factor: 7.293

2.  Branched-chain amino acid treatment before transcatheter arterial chemoembolization for hepatocellular carcinoma.

Authors:  Hiroki Nishikawa; Yukio Osaki; Tadashi Inuzuka; Haruhiko Takeda; Jun Nakajima; Fumihiro Matsuda; Shinichiro Henmi; Azusa Sakamoto; Tetsuro Ishikawa; Sumio Saito; Ryuichi Kita; Toru Kimura
Journal:  World J Gastroenterol       Date:  2012-03-28       Impact factor: 5.742

Review 3.  Branched-chain amino acids in liver diseases.

Authors:  Kazuto Tajiri; Yukihiro Shimizu
Journal:  Transl Gastroenterol Hepatol       Date:  2018-07-30

4.  Radiofrequency ablation for hepatocellular carcinoma: the relationship between a new grading system for the ablative margin and clinical outcomes.

Authors:  Hiroki Nishikawa; Yukio Osaki; Eriko Iguchi; Haruhiko Takeda; Fumihiro Matsuda; Jun Nakajima; Azusa Sakamoto; Keiichi Hatamaru; Sumio Saito; Akihiro Nasu; Ryuichi Kita; Toru Kimura
Journal:  J Gastroenterol       Date:  2012-10-12       Impact factor: 7.527

Review 5.  Early administration of branched-chain amino acid granules.

Authors:  Toru Ishikawa
Journal:  World J Gastroenterol       Date:  2012-09-07       Impact factor: 5.742

Review 6.  Skeletal Muscle Loss during Multikinase Inhibitors Therapy: Molecular Pathways, Clinical Implications, and Nutritional Challenges.

Authors:  Emanuele Rinninella; Marco Cintoni; Pauline Raoul; Carmelo Pozzo; Antonia Strippoli; Francesca Romana Ponziani; Maurizio Pompili; Emilio Bria; Giampaolo Tortora; Antonio Gasbarrini; Maria Cristina Mele
Journal:  Nutrients       Date:  2020-10-12       Impact factor: 5.717

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.